Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism
Authors
Keywords
-
Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 26, Issue 7, Pages 1425-1436
Publisher
Wiley
Online
2011-02-02
DOI
10.1002/jbmr.345
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sclerostin and the regulation of bone formation: Effects in hip osteoarthritis and femoral neck fracture
- (2010) Jon Power et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats
- (2010) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
- (2010) Desmond Padhi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Regulation of circulating sclerostin levels by sex steroids in women and in men
- (2010) Ulrike IL Mödder et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women
- (2010) Matthew T. Drake et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss
- (2010) Agostino Gaudio et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by γ-carboxylation-dependent and -independent mechanisms
- (2009) Gerald J. Atkins et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles
- (2009) Gerald J. Atkins et al. BIOMATERIALS
- Pro-Inflammatory Cytokines TNF-Related Weak Inducer of Apoptosis (TWEAK) and TNFα Induce the Mitogen-Activated Protein Kinase (MAPK)-Dependent Expression of Sclerostin in Human Osteoblasts*
- (2009) Cristina Vincent et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin in Mineralized Matrices and van Buchem Disease
- (2009) R.L. van Bezooijen et al. JOURNAL OF DENTAL RESEARCH
- Localization ofSOST/sclerostin in cementocytesin vivoand in mineralizing periodontal ligament cellsin vitro
- (2009) A. Jäger et al. JOURNAL OF PERIODONTAL RESEARCH
- Novel Regulators of Fgf23 Expression and Mineralization in Hyp Bone
- (2009) Shiguang Liu et al. MOLECULAR ENDOCRINOLOGY
- Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo
- (2009) Hong Y. Choi et al. PLoS One
- Osteocyte-Derived Sclerostin Inhibits Bone Formation: Its Role in Bone Morphogenetic Protein and Wnt Signaling
- (2008) Peter ten Dijke et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- MEPE-ASARM Peptides Control Extracellular Matrix Mineralization by Binding to Hydroxyapatite: An Inhibition Regulated by PHEX Cleavage of ASARM
- (2008) William N Addison et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Matrix Mineralization as a Trigger for Osteocyte Maturation
- (2008) Kazuharu Irie et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response
- (2008) G. J. Atkins et al. OSTEOPOROSIS INTERNATIONAL
- Degradation of MEPE, DMP1, and Release of SIBLING ASARM-Peptides (Minhibins): ASARM-Peptide(s) Are Directly Responsible for Defective Mineralization in HYP
- (2007) Aline Martin et al. ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now